359 filings
Page 6 of 18
8-K
ATXI
Avenue Therapeutics Inc
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
PRE 14A
ATXI
Avenue Therapeutics Inc
Preliminary proxy
8 Nov 22
4:35pm
8-K
ATXI
Avenue Therapeutics Inc
8 Nov 22
Completion of Acquisition or Disposition of Assets
8:40am
8-K
ATXI
Avenue Therapeutics Inc
4 Nov 22
Departure of Directors or Certain Officers
4:25pm
SC 13D/A
InvaGen Pharmaceuticals, Inc.
19 Oct 22
AVENUE THERAPEUTICS / InvaGen Pharmaceuticals ownership change
7:26am
8-K
ATXI
Avenue Therapeutics Inc
18 Oct 22
Other Events
5:19pm
SC 13G
CVI Investments, Inc.
17 Oct 22
AVENUE THERAPEUTICS / CVI Investments ownership change
12:01pm
SC 13G
Intracoastal Capital, LLC
17 Oct 22
AVENUE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:01am
4
InvaGen Pharmaceuticals, Inc.
13 Oct 22
Change in insider ownership
8:52pm
8-K
ATXI
Avenue Therapeutics Inc
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
ATXI
Avenue Therapeutics Inc
11 Oct 22
Prospectus supplement with pricing info
8:27am
EFFECT
ATXI
Avenue Therapeutics Inc
7 Oct 22
Notice of effectiveness
12:15am
FWP
ATXI
Avenue Therapeutics Inc
6 Oct 22
Free writing prospectus
4:05pm
S-1/A
ATXI
Avenue Therapeutics Inc
IPO registration (amended)
6 Oct 22
8:04am
CORRESP
ATXI
Avenue Therapeutics Inc
5 Oct 22
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
5 Oct 22
Correspondence with SEC
12:00am
S-1/A
ATXI
Avenue Therapeutics Inc
IPO registration (amended)
4 Oct 22
6:04pm
8-K
ATXI
Avenue Therapeutics Inc
30 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
ATXI
Avenue Therapeutics Inc
22 Sep 22
Material Modifications to Rights of Security Holders
4:32pm
UPLOAD
ATXI
Avenue Therapeutics Inc
2 Sep 22
Letter from SEC
12:00am